The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers
Open accessPublished version of a preprint
Abstract
Background and aims: Two of the most lethal gastrointestinal (GI) cancers, gastric cancer (GC) and colon cancer (CC), are ranked in the top five cancers that cause deaths worldwide. Most GI cancer deaths can be reduced by earlier detection and more appropriate medical treatment. Unlike the current “gold standard” techniques, non-invasive and highly sensitive screening tests are required for GI cancer diagnosis. Here, we explored the potential of metabolomics for GI cancer detection and the classification of tissue-of-origin, and even the prognosis management. Methods: Plasma samples from 37 gastric cancer (GC), 17 colon cancer (CC), and 27 non-cancer (NC) patients were prepared for metabolomics and lipidomics analysis by three MS-based platforms. Univariate, multivariate, and clustering analyses were used for selecting significant metabolic features. ROC curve analysis was based on a series of different binary classifications as well as the true-positive rate (sensitivity) and the false-positive rate (1-specificity). Results: GI cancers exhibited obvious metabolic perturbation compared with benign diseases. The differentiated metabolites of gastric cancer (GC) and colon cancer (CC) were targeted to same pathways but with different degrees of cellular metabolism reprogramming. The cancer-specific metabolites distinguished the malignant and benign, and classified the cancer types. We also applied this test to before- and after-surgery samples, wherein surgical resection significantly altered the blood-metabolic patterns. There were 15 metabolites significantly altered in GC and CC patients who underwent surgical treatment, and partly returned to normal conditions. Conclusion: Blood-based metabolomics analysis is an efficient strategy for GI cancer screening, especially for malignant and benign diagnoses. The cancer-specific metabolic patterns process the potential for classifying tissue-of-origin in multi-cancer screening. Besides, the circulating metabolites for prognosis management of GI cancer is a promising area of research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Ubiquinone and other terpenoid–quinone biosyntheses, phenylalanine, tyrosine, and tryptophan biosynthesis, histidine metabolism, starch and sucrose metabolism, fructose and mannose metabolism, and inositol phosphate metabolism were associated with GC patients.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“The levels of PE 38:4, threonic acid, l-lysyl-l-glutamine, and temorine were relatively high after GC surgery.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, metabolic patterns changed before- and after surgical procedures in GC.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“MS-based platforms analyzed plasma samples, and 133 metabolites were significantly altered in the GC samples.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“Pathway enrichment analysis displayed that they are principally involved in steroid hormone biosynthesis, cysteine and methionine metabolism, arginine and proline metabolism, galactose metabolism, amino acids, and purine metabolism pathways.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Cancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,226
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“A study by Song and colleagues attempted to detect metabolic features for gastrointestinal cancer prognostic assessment [63].”
BackgroundKlekowski, J., Chabowski, M., Krzystek‐Korpacka, M., & Fleszar, M. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147722 · Cited by 18
“The tumor microenvironment (TME) relies heavily on cytokine activity, which regulates metabolism across numerous pathways.”
BackgroundEvaluation of metabolite stability in dried blood spot stored at different temperatures and times
Cui, H.-N., Shi, F., Huang, G., He, Y., Yu, S., Liu, L., Li, Y., & Wen, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-82041-2 · Cited by 12
Self-citationAtta, S., Zhao, Y., Yampolsky, S. V., Sanchez, S., & Vo‐Dinh, T. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c01765 · Cited by 11
Xie, Y., Jin, Y.-Y., Liu, Z.-D., Li, J., Tao, Q., Wu, Y.-H., Chen, Y., & Zeng, C. (2025) · Cancer Medicine · doi:10.1002/cam4.70762 · Cited by 6
“Similarly, 3-(1H- indol- 3-yl)- 2-(trimethy lammonio) propanoate has been identified as a potential bio-marker for gastrointestinal cancers [22], indicating that it may not be specific to CRP but could also be influenced by other gastrointestinal disorders.”
Metadata
- Authors
- Song, G., Wang, L., Tang, J., Li, H., Pang, S., Li, Y., Liu, L., & Hu, J.
- Affiliations
- Second Hospital of Tianjin Medical University (CN)
- Corresponding author
- Liu, Li
- Hu, Junyuan
- Venue
- Metabolomics
- Published
- 2023-04-04
- Volume
- 19
- Issue
- 4
- Pages
- 36-36
- ISSN
- 1573-3882 (ISSN-L)
- 1573-3890
- PMC
- PMC10073066
- OpenAlex
- W4362523860
- Cited by
- 25
- References
- 60
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 9
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Metabolomics (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Physical Sciences › Engineering › Biomedical Engineering › Advanced Chemical Sensor Technologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- circulating metabolites, biomarkers, gastrointestinal cancer, gastric cancer, colon cancer, cancer screening, early detection, prognosis, plasma metabolomics, lipidomics, surgical resection
- MeSH terms
- Colonic Neoplasms, Gastrointestinal Neoplasms, Humans, Prognosis, Stomach Neoplasms, Biomarkers, Tumor, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers. https://app.cochat.ai/papers/10.1007/s11306-023-02002-0
- The paper
- Song, G., Wang, L., Tang, J., Li, H., Pang, S., Li, Y., Liu, L., & Hu, J. (2023). Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers. Metabolomics. https://doi.org/10.1007/s11306-023-02002-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.